Lowering β-Amyloid Levels Rescues Learning and Memory in a Down Syndrome Mouse Model
William J. Netzer, Craig Powell, Yi Nong et al. · 2010
Read Lowering β-Amyloid Levels Rescues Learning and Memory in a Down Syndrome Mouse Model by William J. Netzer, Craig Powell, Yi Nong et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010943.txt.
Description
William Netzer, Craig Powell, Yi Nong and co-authors published this Down syndrome study in PLOS ONE in 2010. People with Down syndrome carry high levels of beta-amyloid, the protein that builds plaques in Alzheimer's disease, throughout their lives. That load is blamed for dementia in older adults with the condition, but whether it also harms learning in the young was unknown.
The authors gave young mice that model Down syndrome a drug that blocks an enzyme needed to make beta-amyloid. Lowering the protein corrected the learning problems typical of these mice. Netzer and colleagues argue the same protein may drag down thinking long before dementia begins. Their result raises the possibility that amyloid-lowering treatments, developed for Alzheimer's, could also help younger people with Down syndrome learn.
Catalog record
| CREATOR | William J. Netzer, Craig Powell, Yi Nong et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010943